Drugs / Ethinyl estradiol/norethindrone
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00004763 | Jan 1993 → ? | — | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ethinyl estradiol/norethindrone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004763 ↗ |
| Known as | Ovcon 35 | “Patients are randomly assigned to a 6-month course of leuprolide versus ethinyl estradiol/norethindrone (Ovcon 35) versus leuprolide plus Ovcon 35.” NCT00004763 ↗ |
| Route | Oral | “oral contraceptive therapy” NCT00004763 ↗ |